Back to top
more

Biolase (BIOL)

(Delayed Data from OTC)

$0.07 USD

0.07
200,727

-0.01 (-14.62%)

Updated Jul 25, 2024 03:52 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 42% (105 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Ecolab Introduces New Automated Precision Dispensing System

by Zacks Equity Research

Ecolab's (ECL) newly launched Precision Dispensing System for Membranes can drive productivity and boost worker safety.

Masimo Unveils New Wearable Wireless Continuous Thermometer

by Zacks Equity Research

Masimo's (MASI) wearable wireless continuous thermometer offers consumers hassle-free continuous body temperature measurements, thereby eliminating the need for manual measurements.

    Here's Why You Should Retain Fresenius Medical Stock Now

    by Zacks Equity Research

    Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services. However, intense competition remains a woe.

    BD Gets 510(k) Clearance for Its FACSLyric Flow Cytometer

    by Zacks Equity Research

    BD (BDX) gets 510(k) clearance from the FDA for its new integrated system that helps clinical laboratories to fully automate the sample to answer process and boost their efficiency.

    BD Gets CE Mark for Point-of-Care Coronavirus Antigen Test

    by Zacks Equity Research

    BD (BDX) receives CE mark for its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor Plus System.

    Here's Why You Should Retain Cardinal Health Stock for Now

    by Zacks Equity Research

    Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment, diversified product portfolio and strategic buyouts.

    Here's Why You Should Invest in LHC Group (LHCG) Stock Now

    by Zacks Equity Research

    LHC Group (LHCG) continues to gain traction from its broad range of services, and strategic acquisitions and joint ventures.

    Here's Why You Should Retain Change Healthcare (CHNG) Stock

    by Zacks Equity Research

    Change Healthcare (CHNG) continues to benefit from robust payment accuracy business and strategic deals. However, intense competition remains a woe.

    Surmodics' Pounce Thrombus Retrieval System Gets FDA Nod

    by Zacks Equity Research

    The FDA clearance of Surmodics' (SRDX) Pounce Thrombus Retrieval System will bolster the current treatment of complex PAD.

    AquaBounty (AQB) Surges: Stock Moves 6.3% Higher

    by Zacks Equity Research

    AquaBounty (AQB) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

    I-Mab (IMAB) Surges: Stock Moves 5.5% Higher

    by Zacks Equity Research

    I-Mab (IMAB) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

    The Cooper (COO) Soars: Stock Adds 5.4% in Session

    by Zacks Equity Research

    The Cooper (COO) saw a big move last session, as its shares jumped nearly 5% on the day, amid huge volumes.

    Here's Why You Should Invest in Wright Medical Stock Now

    by Zacks Equity Research

    Wright Medical (WMGI) continues to benefit from strong international sales, new product launches and solid prospects in the global Orthopedic space.

    Urmimala Biswas headshot

    Will MedTech Ease Investors' Concern & Outperform? 4 Picks

    by Urmimala Biswas

    Lower investment in MedTech might prove to be a concern, more so as gains within this space are staggering.